PMCPA Case
| Case number | AUTH/2846/5/16 |
| Company | Janssen |
| Case type | Voluntary admission (treated as a complaint under Paragraph 5.6 of the Constitution and Procedure) |
| Issue | Failure to sit the ABPI representatives examination within one year of commencing a sales management role |
| Role start | Autumn/September 2014 |
| When requirement was re-confirmed internally | April 2016 (medical director confirmed exam required) |
| Complaint received | 20 May 2016 (HTML) / 23 May 2016 (PDF) |
| Case completed | 04 July 2016 |
| Applicable Code year | 2016 |
| Breach clauses | 9.1, 16.3 |
| Sanctions | Undertaking received; Additional sanctions: Not stated |
| Appeal | No appeal |
Download the full case report (PDF)
Reviewed by Dr Anzal Qurbain (FFPM) — ABPI Final Signatory
Got a question about this case?
Ask one of our 13 specialist ABPI advisors — instant answers, 24/7.
⭐ Business Intelligence Access
See the full compliance picture for every pharma company
291 Company Intelligence Reports — breach patterns, appeal history, industry ranking, PDF export.
One real case. One key lesson. Every week — free.